Security key
00653A107
Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY)
CUSIP: 00653A107
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / American Depositary Shares, each representing 6 Ordinary Shares
- Total 13F shares
- 143,571,040
- Total 13F value
- $113,849,906
- Share change
- -4,772,011
- SEC-reported price per share
- $0.79
- Number of holders
- 76
- Value change
- -$3,752,852
- Number of buys
- 24
- Number of sells
- 38
- Shares outstanding
- 1,571,428,571
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
76
Top holders
10
ADAPY full security history
Ownership snapshot
Full 13F holder table
Adaptimmune Therapeutics PLC SEC filings
Adaptimmune Therapeutics PLC company facts
Broader feeds
Ownership snapshot
Top reported holders of ADAPY - Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F
Lead comparable stake: 2.5%
Showing 1-6 of 15 holder rows.
Quick read
Matrix Capital Management Company, LP leads the comparable SEC ownership view at 2.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership
Top 5
Matrix Capital Management Company...
2.5%
BAILLIE GIFFORD & CO
1.1%
NEA Management Company, LLC
1.1%
BAKER BROS. ADVISORS LP
0.7%
Long Focus Capital Management, LLC
0.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP |
13F
Company
|
2.5%
|
$30,399,864
38,974,185 shares
|
— | 30 Sep 2023 |
| BAILLIE GIFFORD & CO |
13F
Company
|
1.1%
|
$13,374,980
17,147,409 shares
|
— | 30 Sep 2023 |
| NEA Management Company, LLC |
13F
Company
|
1.1%
|
$13,322,227
17,079,778 shares
|
— | 30 Sep 2023 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
0.7%
|
$8,556,040
10,969,282 shares
|
— | 30 Sep 2023 |
| Long Focus Capital Management, LLC |
13F
Company
|
0.7%
|
$8,551,263
10,963,158 shares
|
— | 30 Sep 2023 |
| PFM Health Sciences, LP |
13F
Company
|
0.66%
|
$8,130,045
10,423,135 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
143,571,040
Rows available
76
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
77
Q4 2023 holders
76
Holder diff
-1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|